Totus Medicines
PrivateLast Round
Series B
Dec 15, 2023
Total Funding Raised
$109M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Totus Medicines is a biotechnology company that develops precision oral medicines for previously untreatable diseases using its proprietary AI-powered OmniDEL drug discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Totus Medicines Comparables
Compare Totus Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Frontier Medicines | 89% | |
| Matchpoint Therapeutics | 86% | |
| Nexo Therapeutics | 85% | |
Totus Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 15, 2023 | ||||
| Series A | Dec 9, 2021 |
Key People
Founding team and executive leadership
Totus Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DCVC Bio | Series A, Series B |
| Camford Capital | Series A, Series B |
| Northpond Ventures | Series B, Series A |
| Social Impact Capital | Series A, Pre Seed, Seed |
| University of Minnesota | Series B |
| Northpond Ventures | Series B, Series A |
| Camford Capital | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Presenting data on covalent IRF5 inhibitor at AAI IMMUNOLOGY2026.
- Apr 16, 2026
Presenting data at the AAI IMMUNOLOGY2026 event.
Totus Medicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Totus Medicines's valuation, stock price, and market status.